Skip to main content
. Author manuscript; available in PMC: 2023 Mar 1.
Published in final edited form as: Optom Vis Sci. 2022 Mar 1;99(3):213–227. doi: 10.1097/OPX.0000000000001867

Figure 1.

Figure 1.

Visit completion by treatment group. The 4-week primary outcome visits were classified as being within the analysis window if completed between 21 to <49 days from randomization. The 8-week visits were classified as being within the analysis window if completed between 49 to <105 days from randomization. The 16-week visits were classified as being within the analysis window if completed between 105 to <161 days from randomization.